Advertisement

Corticotropin-releasing factor, norepinephrine, and stress

  • George F Koob
    Correspondence
    Address reprint requests to George F. Koob, PhD, Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037
    Affiliations
    Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
    Search for articles by this author

      Abstract

      Corticotropin-releasing factor (CRF) and related peptides in the central nervous system appears to have activating properties on behavior and to enhance behavioral responses to stressors. CRF and urocortin injected into the brain produces increases in arousal as measured by locomotor activation and increased responsiveness to stressful stimuli. These effects of CRF appear to be independent of the pituitary adrenal axis and can be reversed by specific and selective CRF antagonists alpha-helical CRF9–41 and D-Phe CRF12–41. Perhaps more importantly, CRF antagonists can reverse behavioral responses to many stressors. These results suggest that endogenous CRF systems in the brain may have a role in mediating behavioral responses to stressors. Norepinephrine systems emanating from the nucleus locus coeruleus also long have been hypothesized to be involved in mediating behavioral constructs associated with alertness, arousal, and stress. Pharmacologic, physiologic, and neuroanatomic evidence supports an important role for a CRF–norepinephrine interaction in the region of the locus coeruleus in response to stressors that may be modality- specific where CRF neurons activate the locus coeruleus. One may hypothesize that another norepinephrine–CRF interaction may occur in the terminal projections of the forebrain norepinephrine systems in the paraventricular nucleus of the hypothalamus, the bed nucleus of the stria terminalis, and the central nucleus of the amygdala where norepinephrine stimulates CRF release. Such a feed-forward system may be particularly important in situations where an organism must mobilize not only the pituitary adrenal system but also the central nervous system, in response to environmental challenge. However, such a feed-forward mechanism in a fundamental brain-activating system may be particularly vulnerable to dysfunction and thus, may be the key to a variety of pathophysiologic conditions involving abnormal responses to stressors such as anorexia nervosa, anxiety, and affective disorders.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abercrombie E.D.
        • Keller R.W.
        • Zigmond M.J.
        Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion.
        Neuroscience. 1988; 27: 897-904
        • Aldenhoff J.B.
        • Groul D.L.
        • Rivier J.
        • Vale W.
        • Siggins G.R.
        Corticotropin-releasing factor decreases post-burst hyperpolarization and excites hippocampal pyamidal neurons in vitro.
        Science. 1983; 221: 875-876
        • Alonso G.
        • Szafarczyk A.
        • Balmefrezol M.
        • Assenmacher I.
        Immunocytochemical evidence for stimulatory control by ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin-releasing hormone and vasopressin in rats.
        Brain Res. 1986; 397: 297-307
        • Arase K.
        • York D.A.
        • Shimizu H.
        • Shargill N.
        • Bray G.A.
        Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats.
        Am J Physiol. 1988; 255: E255-E259
      1. Baldwin HA, Britton KT, Koob GF (1990): Behavioral effects of corticotropin-releasing factor. In: Pfaff DW, Ganten D, editors. Behavioral Aspects of Neuroendocrinology, (series title: Current Topics in Neuroendocrinology, vol. 10). Berlin: Springer-Verlag, pp 1–14.

        • Baldwin H.A.
        • Rassnick S.
        • Rivier J.
        • Koob G.F.
        • Britton K.T.
        CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat.
        Psychopharmacology. 1991; 103: 227-232
        • Baram T.Z.
        • Chalmers D.T.
        • Chen C.
        • Koutsoukos Y.
        • De Souza E.B.
        The CRF1 receptor mediates the excitatory actions of corticotropin-releasing factor (CRF) in the developing rat brain.
        Brain Res. 1997; 770: 89-95
        • Berridge C.W.
        • Dunn A.J.
        Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice.
        Regul Pept. 1986; 16: 83-93
        • Berridge C.W.
        • Dunn A.J.
        A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice.
        Horm Behav. 1987; 21: 393-401
        • Biro E.
        • Sarnyai Z.
        • Penke B.
        • Szabo G.
        • Telegdy G.
        Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.
        Neuroendocrinology. 1993; 57: 340-345
        • Bloom F.E.
        • Battenberg E.L.
        • Rivier J.
        • Vale W.
        Corticotropin-releasing factor (CRF).
        Regul Pept. 1982; 4: 43-48
        • Britton D.R.
        • Hoffman D.K.
        • Lederis K.
        • Rivier J.A.
        Comparison of the behavioral effects of CRF, sauvagine and urotensin I.
        Brain Res. 1984; 304: 201-205
        • Britton D.R.
        • Koob G.F.
        • Rivier J.
        • Vale W.
        Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.
        Life Sci. 1982; 31: 363-367
        • Britton D.R.
        • Varela M.
        • Garcia A.
        • Rivier J.
        Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.
        Life Sci. 1986; 38: 211-216
        • Britton K.
        • Morgan J.
        • Rivier J.
        • Vale W.
        • Koob G.F.
        Chlordiazepoxide attenuates CRF-induced response suppression in the conflict test.
        Psychopharmacology. 1985; 86: 170-174
        • Brown M.R.
        • Fisher L.A.
        • Rivier J.
        • Spiess J.
        • Rivier C.
        • Vale W.
        Corticotropin-releasing factor.
        Life Sci. 1982; 30: 207-210
        • Burchfield S.
        The stress responses.
        Psychosom Med. 1979; 41: 661-672
        • Butler P.D.
        • Weiss J.M.
        • Stout J.C.
        • Kilts C.D.
        • Cook L.L.
        • Nemeroff C.B.
        Corticotropin-releasing factor produces anxiogentic and behavioral activating effects following microinfusion into the locus coereuleus.
        Neurosci Abstr. 1988; 14: 288
        • Cador M.
        • Ahmed S.H.
        • Koob G.F.
        • Le Moal M.
        • Stinus L.
        Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role.
        Brain Res. 1992; 41: 61-69
        • Chalmers D.T.
        • Lovenberg T.W.
        • De Souza E.B.
        Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain.
        J Neurosci. 1995; 15: 6340-6350
        • Chappell P.B.
        • Smith M.A.
        • Hilts C.D.
        • Bissette G.
        • Ritchie J.
        • Andersen C.
        • et al.
        Alterations in corticotropin-releasing factor-line immunoreactivity in discrete rat brain regions after acute and chronic stress.
        J Neurosci. 1986; 10: 2908-2916
        • Chen M.F.
        • Chiu T.H.
        • Lee E.H.Y.
        Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus.
        Psychoneuroendocrinology. 1992; 17: 113-124
        • Cole B.J.
        • Britton K.T.
        • Koob G.F.
        Central administration of alpha-helical corticotropin-releasing factor attenuates the acquisition of a conditioned emotional response.
        Neurosci Abstr. 1987; 13: 427
        • Cole B.J.
        • Cador M.
        • Stinus L.
        • Rivier J.
        • Vale W.
        • Koob G.F.
        • et al.
        Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization.
        Brain Res. 1990; 512: 343-346
        • Cole B.J.
        • Koob G.F.
        Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor.
        J Pharmacol Exp Ther. 1988; 247: 902-910
      2. Contarino A, Dellu F, Koob GF, Smith GW, Lee K-F, Vale W, et al (1999): Dissociation of locomotor activation and suppression of food intake induced by CRF-related peptides in CRFR1-deficient mice. (unpublished work)

        • Cummings S.
        • Elde R.
        • Ells J.
        • Lindall A.
        Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat.
        J Neurosci. 1983; 3: 1355-1368
        • Curtis A.L.
        • Grigoriadis D.E.
        • Page M.E.
        • Rivier J.
        • Valentino R.J.
        Pharmacological comparison of two corticotropin-releasing factor antagonists.
        J Pharmacol Exp Ther. 1994; 268: 359-365
        • Curtis A.L.
        • Lechner S.M.
        • Pavcovich L.A.
        • Valentino R.J.
        Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor.
        J Pharmacol Exp Ther. 1997; 281: 163-172
        • Curtis A.L.
        • Pavcovich L.A.
        • Valentino R.J.
        Long-term regulation of locus coeruleus sensitivity to corticotropin-releasing factor by swim stress.
        J Pharmacol Exp Ther. 1999; 289: 1211-1219
        • Dagnault A.
        • Ouerghi D.
        • Richard D.
        Treatment with alpha-helical-CRF (9–41) prevents the anorectic effect of 17-beta-estradiol.
        Brain Res Bull. 1993; 32: 689-692
        • De Boer S.F.
        • Katz J.L.
        • Valentino R.J.
        Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
        J Pharmacol Exp Ther. 1992; 262: 335-342
        • De Pedro N.
        • Alonso-Gomez A.L.
        • Gancedo B.
        • Delgado M.J.
        • Alonso-Bedate M.
        Role of corticotropin-releasing factor (CRF) as a food intake regulator in goldfish.
        Physiol Behav. 1993; 53: 517-520
        • De Souza E.B.
        Corticotropin-releasing factor receptors in the rat central nervous system.
        J Neurosci. 1987; 7: 88-100
        • Diamant M.
        • Croiset G.
        • De Weid D.
        The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats.
        Peptides. 1992; 13: 1149-1158
        • Dunn A.J.
        • Berridge C.W.
        Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
        Pharmacol Biochem Behav. 1987; 27: 685-691
        • Dunn A.J.
        • Berridge C.W.
        Physiological and behavioral responses to corticotropin-releasing factor administration.
        Brain Res Rev. 1990; 15: 71-100
        • Eaves M.
        • Britton K.T.
        • Rivier J.
        • Vale W.
        • Koob G.F.
        Effects of corticotropin-releasing factor on locomotor activity in hypophysectomized rats.
        Peptides. 1985; 6: 923-926
        • Ehlers C.L.
        • Henriksen S.J.
        • Wang M.
        • Rivier J.
        • Vale W.
        • Bloom F.E.
        Corticotropin-releasing factor produces increases in brain excitability and convulsive seizures in the rat.
        Brain Res. 1983; 278: 332-336
        • Fazal N.
        • Slominski A.
        • Choudhry M.A.
        • Wei E.T.
        • Sayeed M.M.
        Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells.
        FEBS Lett. 1998; 435: 187-190
        • Fisher L.A.
        • Rivier J.
        • Rivier C.
        • Spiess J.
        • Vale W.
        • Brown M.
        Corticotropin-releasing factor (CRF).
        Endocrinology. 1982; 110: 2222-2224
        • Foote S.L.
        • Aston-Jones G.S.
        Pharmacology and physiology of central noradrenergic systems.
        in: Bloom F.E. Kupfer D.J. Psychopharmacology The Fourth Generation of Progress. Raven Press, New York1995: 335-345
        • Gold P.W.
        • Goodwin F.K.
        • Chrousos G.P.
        Clinical and biochemical manifestations of depressions.
        N Engl J Med. 1988; 319: 348-353
        • Gold P.W.
        • Goodwin F.K.
        • Chrousos G.P.
        Clinical and biochemical manifestations of depression.
        N Engl J Med. 1988; 319: 413-420
        • Gray T.S.
        • Magnuson D.J.
        Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat.
        J Comp Neurol. 1987; 262: 365-374
        • Heinrichs S.C.
        • Britton K.T.
        • Koob G.F.
        Both conditioned taste preference and aversion induced by corticotropin-releasing factor.
        Pharmacol Biochem Behav. 1991; 40: 717-721
        • Heinrichs S.C.
        • Cole B.J.
        • Pich E.M.
        • Menzaghi F.
        • Koob G.F.
        • Hauger R.L.
        Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail pinch stressor.
        Peptides. 1992; 13: 879-884
        • Heinrichs S.C.
        • Koob G.F.
        Corticotropin-releasing factor modulates dietary preference in nutritionally stressed, self-selecting rats.
        Psychopharmacology. 1992; 109: 177-184
        • Heinrichs S.C.
        • Menzaghi F.
        • Pich E.M.
        • Baldwin H.A.
        • Rassnick S.
        • Britton K.T.
        • et al.
        Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.
        Neuropsychopharmacology. 1994; 11: 179-186
        • Heinrichs S.C.
        • Menzaghi F.
        • Pich E.M.
        • Hauger R.L.
        • Koob G.F.
        Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y.
        Brain Res. 1993; 611: 18-24
        • Heinrichs S.C.
        • Pich E.M.
        • Miczek K.
        • Britton K.T.
        • Koob G.F.
        Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
        Brain Res. 1992; 581: 190-197
        • Hennessy J.W.
        • Levine S.
        Stress, arousal, and the pituitary-adrenal system.
        in: Sprague J.M. Epstein A.N. Progress in Psychobiology and Physiological Psychology. 8th ed. Academic Press, New York1979: 133-178
        • Imaki T.
        • Shibasaki T.
        • Masuda A.
        • Demura H.
        • Shizume K.
        • Ling N.
        Effects of adrenergic blockers on corticotropin-releasing factor-induced behavioral changes in rats.
        Regul Pept. 1987; 19: 243-252
        • Jones D.N.
        • Kortekaas R.
        • Slade P.D.
        • Middlemiss D.N.
        • Hagan J.J.
        The behavioural effects of corticotropin-releasing factor-related peptides in rats.
        Psychopharmacology. 1998; 138: 124-132
        • Kalin N.H.
        • Sherman J.E.
        • Takahashi L.K.
        Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats.
        Brain Res. 1988; 457: 130-135
        • Koob G.F.
        • Cador M.
        Psychomotor stimulant sensitization.
        Behav Pharmacol. 1993; 4: 351-354
        • Koob G.F.
        • Heinrichs S.C.
        • Menzaghi F.
        • Pich E.M.
        • Britton K.T.
        Corticotropin-releasing factor, stress, and behavior.
        Semin Neurosci. 1994; 6: 221-229
        • Koob G.F.
        • Swerdlow N.
        • Seeligson M.
        • Eaves M.
        • Sutton R.
        • Rivier J.
        • et al.
        CRF-induced locomotor activation is antagonized by alpha flupenthixol but not naloxone.
        Neuroendocrinology. 1984; 39: 459-464
        • Korf J.
        • Aghajanian G.K.
        • Roth R.
        Increased turnover of norepinephrine in the rat cerebral cortex during stress.
        Neuropharmacology. 1973; 12: 933-938
        • Korte S.M.
        • Korte-Bouws G.A.H.
        • Bohus B.
        • Koob G.F.
        The effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
        Physiol Behav. 1994; 56: 115-120
        • Kozicz T.
        • Yanaihara H.
        • Arimura A.
        Distribution of urocortin-like immunoreactivity in the central nervous system of the rat.
        J Comp Neurol. 1998; 391: 1-10
        • Krahn D.D.
        • Gosnell B.A.
        • Grace M.
        • Levine A.S.
        CRF antagonist partially reverses CRF- and stress-induced effects on feeding.
        Brain Res Bull. 1986; 17: 285-289
        • Krahn D.D.
        • Gosnell B.A.
        • Levine A.S.
        • Morley J.E.
        Behavioral effects of corticotropin-releasing factor.
        Brain Res. 1988; 443: 63-69
        • Lechner S.M.
        • Curtis A.L.
        • Brons R.
        • Valentino R.J.
        Locus coeruleus activation by colon distention.
        Brain Res. 1997; 756: 114-124
        • Lee E.H.Y.
        • Tsai M.J.
        The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice.
        Behav Neural Biol. 1989; 51: 412-423
        • Lee Y.
        • Davis M.
        Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
        J Neurosci. 1997; 17: 6434-6446
        • Liang K.C.
        • Lee E.H.Y.
        Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats.
        Psychopharmacology. 1988; 96: 232-236
        • Liang K.C.
        • Melia K.R.
        • Campeau S.
        • Falls W.A.
        • Miserendino M.J.
        • David M.
        Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
        J Neurosci. 1992; 12: 2313-2320
        • Liang K.C.
        • Melia K.R.
        • Miserendino M.J.
        • Falls W.A.
        • Campeau S.
        • Davis M.
        Corticotropin-releasing factor.
        J Neurosci. 1992; 12: 2303-2312
        • Liposits Z.
        • Phelix C.
        • Paull W.K.
        Synaptic interaction of serotonergic axons and corticotropin-releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat.
        Histochemistry. 1987; 86: 541-549
        • Lovenberg T.W.
        • Liaw C.W.
        • Grigoriadis D.E.
        • Clevenger W.
        • Chalmers D.T.
        • De Souza E.B.
        • et al.
        Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
        Proc Natl Acad Sci U S A. 1995; 92: 836-840
        • Marrosu F.
        • Mereu G.
        • Fratta W.
        • Carcangiu P.
        • Camarri F.
        • Gessa G.L.
        Different epileptogenic activities of murine and ovine corticotropin-releasing factor.
        Brain Res. 1987; 408: 394-398
        • Menzaghi F.
        • Heinrichs S.C.
        • Merlo-Pich E.
        • Tilders F.J.H.
        • Koob G.F.
        Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats.
        Neurosci Lett. 1994; 168: 139-142
        • Menzaghi F.
        • Heinrichs S.C.
        • Pich E.M.
        • Tilders F.J.H.
        • Koob G.F.
        Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y.
        Brain Res. 1993; 618: 76-82
        • Menzaghi F.
        • Howard R.L.
        • Heinrichs S.C.
        • Vale W.
        • Rivier J.
        • Koob G.F.
        Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
        J Pharmacol Exp Ther. 1994; 269: 564-572
        • Merali Z.
        • McIntosh J.
        • Kent P.
        • Michaud D.
        • Anisman H.
        Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.
        J Neurosci. 1998; 18: 4758-4766
        • Merlo-Pich E.
        • Lorang M.
        • Yeganeh M.
        • Rodriguez de Fonseca F.
        • Raber J.
        • Koob G.F.
        • et al.
        Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in theamygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.
        J Neurosci. 1995; 15: 5439-5447
        • Moreau J.L.
        • Kilpatrick G.
        • Jenck F.
        Urocortin, a novel neuropeptide with anxiogenic-like properties.
        Neuroreport. 1997; 8: 1697-1701
        • Morley J.E.
        • Levine A.S.
        Corticotropin-releasing factor, grooming and ingestive behavior.
        Life Sci. 1982; 31: 1459-1464
        • Nemeroff C.B.
        • Widerlov E.
        • Bissette G.
        • Walleus H.
        • Karlsson I.
        • Eklund K.
        • et al.
        Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.
        Science. 1984; 226: 1342-1344
        • Pacak K.
        • McCarty R.
        • Palkovits M.
        • Kopin I.J.
        • Goldstein D.S.
        Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats.
        Brain Res. 1995; 688: 242-246
        • Pacak K.
        • Palkovits M.
        • Kopin I.J.
        • Goldstein D.S.
        Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity.
        Front Neuroendocrinol. 1995; 16: 89-150
        • Parkes D.G.
        • Vaughan J.
        • Rivier J.
        • Vale W.
        • May C.N.
        Cardiac intropic actions of urocortin in conscious sheep.
        Am J Physiol. 1997; 272: H2115-H2122
        • Perrin M.
        • Donaldson C.
        • Chen R.
        • Blount A.
        • Berggren T.
        • Bilezikjian L.
        • et al.
        Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.
        Proc Natl Acad Sci U S A. 1995; 92: 2969-2973
        • Perrin M.H.
        • Donaldson C.J.
        • Chen R.
        • Lewis K.A.
        • Vale W.W.
        Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor.
        Endocrinology. 1993; 133: 3058-3061
        • Phelix C.F.
        • Liposits Z.
        • Paull W.K.
        Catecholamine-CRF synaptic interaction in a septal bed nucleus.
        Brain Res Bull. 1994; 33: 109-119
        • Pich E.M.
        • Koob G.F.
        • Sattler S.C.
        • Menzaghi F.
        • Heilig M.
        • Heinrichs S.C.
        • et al.
        Stress-induced release of corticotropin-releasing factor in the amygdala measured by in vivo microdialysis.
        Neurosci Abstr. 1992; 18: 535
        • Post R.M.
        • Weiss S.R.B.
        The neurobiology of treatment-resistant mood disorders.
        in: Bloom F.E. Kupfer D.J. Psychopharmacology The Fourth Generation of Progress. Raven Press, New York1995: 1155-1170
        • Primus R.J.
        • Yevich E.
        • Baltazar C.
        • Gallager D.W.
        Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
        Neuropsychopharmacology. 1997; 17: 308-316
        • Quirarte G.L.
        • Galvez R.
        • Roozendaal B.
        • McGaugh L.
        Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs.
        Brain Res. 1998; 808: 134-140
        • Raber J.
        • Koob G.F.
        • Bloom F.E.
        Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling.
        J Pharmacol Exp Ther. 1995; 272: 815-824
        • Rassnick S.
        • Heinrichs S.C.
        • Britton K.T.
        • Koob G.F.
        Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
        Brain Res. 1993; 605: 25-32
        • Redmond Jr, D.E.
        • Huang Y.H.
        • Snyder D.R.
        • Maas J.W.
        Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-talied monkey (Maccaca arctoides).
        Brain Res. 1976; 116: 502-510
        • Robbins T.W.
        • Everitt B.J.
        Central norepinephrine neurons and behavior.
        in: Bloom F.E. Kupfer D.J. Psychopharmacology The Fourth Generation of Progress. Raven Press, New York1995: 363-372
        • Rodriguez de Fonseca F.
        • Carrera M.R.A.
        • Navarro M.
        • Koob G.F.
        • Weiss F.
        Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
        Science. 1997; 276: 2050-2054
        • Rosenthal M.J.
        • Morley J.E.
        Corticotropin-releasing factor (CRF) and age-related differences in behavior of mice.
        Neurobiol Aging. 1989; 10: 167-171
        • Schulkin J.
        • Gold P.W.
        • McEwen B.S.
        Induction of corticotropin-releasing hormone gene expression by glucocorticoids.
        Psychoneuroendocrinology. 1998; 23: 219-243
        • Selye H.
        A syndrome produced by diverse noxious agents.
        Nature. 1936; 32: 138
        • Sepinwall J.
        • Cook L.
        Behavioral pharmacology of anti-anxiety drugs.
        in: Iversen L.L. Iversen S.D. Snyder S.H. Handbook of Psychopharmacology. vol. 13. Springer-Verlag, New York1978: 345-393
        • Sherman J.E.
        • Kalin N.H.
        The effects of ICV-CRH on novelty-induced behavior.
        Pharmacol Biochem Behav. 1987; 26: 699-703
        • Sherman J.E.
        • Kalin N.H.
        ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.
        Pharmacol Biochem Behav. 1988; 30: 801-807
        • Siggins G.R.
        • Gruol D.
        • Aldenhof J.
        • Pittman Q.
        Electrophysiological actions of corticotropin-releasing factor in the central nervous system.
        Federation Proc. 1985; 44: 237-242
        • Sirinathsinghji D.J.S.
        Regulation of lordosis behavior in the female rat by corticotropin-releasing factor, -endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
        Brain Res. 1986; 375: 49-56
        • Sirinathsinghji D.J.S.
        Inhibitory influence of corticotropin-releasing factor on components of sexual behaviour in the male rat.
        Brain Res. 1987; 407: 185-190
        • Sirinathsinghji D.J.S.
        • Rees L.H.
        • Rivier J.
        • Vale W.
        Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat.
        Nature. 1983; 305: 230-235
        • Smagin G.N.
        • Howell L.A.
        • Ryan D.H.
        • De Souza E.B.
        • Harris R.B.
        The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
        Neuroreport. 1998; 9: 1601-1606
        • Smagin G.N.
        • Swiergiel A.H.
        • Dunn A.J.
        Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex.
        Brain Res Bull. 1995; 36: 71-76
        • Smith G.W.
        • Aubry J.-M.
        • Dellu F.
        • Contarino A.
        • Bilezikjian L.M.
        • Gold L.H.
        • et al.
        Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.
        Neuron. 1998; 20: 1093-1102
        • Spina M.
        • Merlo-Pich E.
        • Chan R.K.W.
        • Basso A.M.
        • Rivier J.
        • Vale W.
        • et al.
        Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.
        Science. 1996; 273: 1561-1564
        • Stenzel-Poore M.P.
        • Heinrichs S.C.
        • Rivest S.
        • Koob G.F.
        • Vale W.W.
        Overproduction of corticotropin-releasing factor in transgenic mice.
        J Neurosci. 1994; 14: 2579-2584
        • Sutton R.E.
        • Koob G.F.
        • Le Moal M.
        • Rivier J.
        • Vale W.
        Corticotropin-releasing factor (CRF) produces behavioral activation in rats.
        Nature. 1982; 297: 331-333
        • Swanson L.W.
        • Sawchenko P.E.
        • Rivier J.
        • Vale W.
        The organization of ovine corticotropin-releasing factor (CRF) immunoreactive cells and fibres in the rat brain.
        Neuroendocrinology. 1983; 36: 165-186
        • Swerdlow N.R.
        • Britton K.T.
        • Koob G.F.
        Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9–41).
        Neuropsychopharmacology. 1989; 2: 285-292
        • Swerdlow N.R.
        • Geyer M.A.
        • Vale W.W.
        • Koob G.F.
        Corticotropin-releasing factor potentiates acoustic startle in rats.
        Psychopharmacology. 1986; 88: 142-152
        • Swiergiel A.H.
        • Takahashi L.K.
        • Kalin N.H.
        Attenuation of stress-induced by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat.
        Brain Res. 1993; 623: 229-234
        • Swiergiel A.H.
        • Takahashi L.K.
        • Rubin W.W.
        • Kalin N.H.
        Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
        Brain Res. 1992; 587: 263-268
        • Takahashi L.K.
        • Kalin N.H.
        • Vandenburgt J.A.
        • Sherman J.E.
        Corticotropin-releasing factor modulates defensive withdrawal and exploratory behavior in rats.
        Behav Neurosci. 1989; 103: 648-654
        • Tazi A.
        • Dantzer R.
        • Le Moal M.
        • Rivier J.
        • Vale W.
        • Koob G.F.
        Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats.
        Regul Pept. 1987; 18: 37-42
        • Timpl P.
        • Spanagel R.
        • Sillaber I.
        • Kreese A.
        • Reul J.M.
        • Stalla G.K.
        • et al.
        Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor.
        Nat Genet. 1998; 19: 162-166
        • Vale W.
        • Spiess J.
        • Rivier C.
        • Rivier J.
        Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and beta-endorphin.
        Science. 1981; 213: 1394-1397
        • Valentino R.J.
        • Curtis A.L.
        • Parris D.G.
        • Wehby R.G.
        Antidepressant actions on brain noradrenergic neurons.
        J Pharmacol Exp Ther. 1990; 253: 833-840
        • Valentino R.J.
        • Foote S.L.
        Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons.
        Neuroendocrinology. 1987; 45: 28-36
        • Valentino R.J.
        • Foote S.L.
        Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats.
        J Neurosci. 1988; 8: 1016-1025
        • Valentino R.J.
        • Foote S.L.
        • Aston-Jones G.
        Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.
        Brain Res. 1983; 270: 363-367
      3. Valentino RJ, Foote SL, Page ME (1993): The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. In: Tache Y, editor. Corticotropin-Releasing Factor and Cytokines: Role in the Stress Response, (series title: Annals of the New York Academy of Sciences, vol. 697). New York: New York Academy of Sciences, pp 173–188.

        • Valentino R.J.
        • Page M.E.
        • Curtis A.L.
        Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor.
        Brain Res. 1991; 555: 25-34
        • Van Bockstaele E.J.
        • Colago E.E.
        • Valentino R.J.
        Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites.
        J Neuroendocrinol. 1998; 10: 743-757
        • Vaughan J.
        • Donaldson C.
        • Bittencourt J.
        • Perrin M.H.
        • Lewis K.
        • Sutton S.
        • et al.
        Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
        Nature. 1995; 378: 287-292
        • Veldhuis H.D.
        • De Weid D.
        Differential behavioral actions of corticotropin-releasing factor (CRF).
        Pharmacol Biochem Behav. 1984; 21: 707-713
      4. Zorrilla EP, Schulteis G, Ormsby A, Klassen A, Ling N, McCarthy JR, et al (1999): Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): Mediation by CRF-1 receptors. (unpublished work)